✦ LIBER ✦

O3-05-08: A randomized double-blind trial with omega-3 fatty acid treatment in mild to moderate Alzheimer’s disease

✍ Scribed by Yvonne Freund-Levi; Maria Eriksdotter Jonhagen; Tommy Cederholm; Hans Basun; Gerd Faxen-Irving; Anita Garlind; Inger Vedin; Bengt Vessby; Lars-Olof Wahlund; Jan Palmblad

Book ID: 118462325
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 56 KB
Volume: 2
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2006.05.230

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined treatment with cerebrolysin and

Combined treatment with cerebrolysin and donepezil in mild to moderate alzheimer's disease: Results of a double-blind, randomized clinical trial

✍ Anton Alvarez; Ramon Cacabelos; Manuel Aleixandre; Carlos Linares; Elias Granizo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 169 KB

The effects of omega-3 fatty acids monot

The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study

✍ Chih-Chiang Chiu; Kuan-Pin Su; Tsung-Chi Cheng; Hsing-Cheng Liu; Ching-Jui Chang 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 450 KB

O3-04-05: Clinical trials of bapineuzuma

O3-04-05: Clinical trials of bapineuzumab, a beta-amyloid-targeted immunotherapy in patients with mild to moderate Alzheimer's disease

✍ Michael Grundman; Ronald Black 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Melissa officinalis extract in the treat

Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial

✍ Akhondzadeh, S 📂 Article 📅 2003 🏛 BMJ Publishing Group 🌐 English ⚖ 224 KB

The effect of low-dose omega 3 fatty aci

The effect of low-dose omega 3 fatty acids on the treatment of mild to moderate depression in the elderly: a double-blind, randomized, placebo-controlled study

✍ Yaser Tajalizadekhoob; Farshad Sharifi; Hossein Fakhrzadeh; Mojde Mirarefin; Mar 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 272 KB

Results from CONNECTION: A global, Phase

Results from CONNECTION: A global, Phase 3 double-blind, placebo-controlled confirmatory trial of dimebon (latrepirdine) in patients with mild-to-moderate Alzheimer's disease

✍ Rachelle S. Doody; Pierre Tariot; Jeff Cummings; Bengt Winblad; Bryan Selby; And 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB